Literature DB >> 6629314

Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model.

J Bosch, R Enriquez, R J Groszmann, E H Storer.   

Abstract

Splanchnic and systemic hemodynamics were measured in six normal dogs and in 18 dogs that had the bile ducts ligated for a period of 8 weeks. In the bile duct-ligated dogs, there was a decrease in arterial pressure (110 +/- 4 mm Hg vs. normal 136 +/- 6 mm Hg; p less than 0.005) and peripheral vascular resistance (4.60 +/- 0.38 vs. 6.28 +/- 0.38 dynes-sec-cm-5; p less than 0.02), and an increase in cardiac index (129 +/- 7 vs. 98 +/- 9 ml per min per kg; p less than 0.05). The splanchnic hemodynamic characteristics in the bile duct-ligated dogs included an increase in portal venous pressure (13.3 +/- 0.6 mm Hg vs. 6.7 +/- 0.5 mm Hg; p less than 001) and wedged hepatic venous pressure (14 +/- 1.2 mm Hg), the development of extensive portal-systemic shunting (49 +/- 10 vs. 0.03 +/- 0.01%; p less than 0.01), and a decrease in portal venous flow (194 +/- 21 ml per min vs. 427 +/- 21 ml per min; p less than 0.001). This study demonstrated that chronic bile duct-ligated dogs develop sinusoidal portal hypertension with extensive portal-systemic shunting and a hyperdynamic systemic circulation. These findings closely resembled hemodynamic abnormalities observed in human cirrhosis and suggest that this model is useful in physiopathological and pharmacological studies of portal hypertension.

Entities:  

Mesh:

Year:  1983        PMID: 6629314     DOI: 10.1002/hep.1840030618

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

Review 1.  Animal models of portal hypertension.

Authors:  Juan-G Abraldes; Marcos Pasarín; Juan-Carlos García-Pagán
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

Review 2.  Therapeutic mechanisms of single Chinese medicine herb or their extracts for extrahepatic obstructive jaundice.

Authors:  Xi-ping Zhang; Feng-mei Qiu; Xia Wang
Journal:  Chin J Integr Med       Date:  2014-01-28       Impact factor: 1.978

3.  An experimental study on the disorders of hepatic hemodynamics and changes of plasma histamine in dogs with fulminant hepatic failure.

Authors:  L Zhang; Q Zhao
Journal:  J Tongji Med Univ       Date:  1998

4.  Hepato-cardiovascular response and its regulation.

Authors:  Xiang-Nong Li; Irving S Benjamin; Barry Alexander
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

5.  Portal hypertension correlates with splenic stiffness as measured with MR elastography.

Authors:  Geir I Nedredal; Meng Yin; Travis McKenzie; Joseph Lillegard; Jennifer Luebke-Wheeler; Jayant Talwalkar; Richard Ehman; Scott L Nyberg
Journal:  J Magn Reson Imaging       Date:  2011-05-23       Impact factor: 4.813

6.  Diminution in parietal cell number in experimental portal hypertensive gastropathy.

Authors:  N Agnihotri; S Kaur; J B Dilawari; S R Bhusnurmath; U Kaur
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

7.  Comparison of radial 4D Flow-MRI with perivascular ultrasound to quantify blood flow in the abdomen and introduction of a porcine model of pre-hepatic portal hypertension.

Authors:  A Frydrychowicz; A Roldan-Alzate; E Winslow; D Consigny; C A Campo; U Motosugi; K M Johnson; O Wieben; S B Reeder
Journal:  Eur Radiol       Date:  2017-06-27       Impact factor: 5.315

8.  Hemodynamic studies in a parabiotic model of portal hypertension.

Authors:  E Sikuler; R J Groszmann
Journal:  Experientia       Date:  1985-10-15

9.  Hemodynamic effects of hypothyroidism induced by methimazole in normal and portal hypertensive rats.

Authors:  R Oren; N Hilzenrat; Y Maaravi; A Yaari; E Sikuler
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

10.  Liver transplantation for the sequelae of intra-operative bile duct injury.

Authors:  E de Santibañes; J Pekolj; L McCormack; J Nefa; J Mattera; J Sívori; C Bonofiglio; A Gadano; M Ciardullo
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.